A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to confirm the safety and effectiveness of rabeprazole in the
treatment of patients with erosive or ulcerative gastroesophageal reflux disease (GERD) in
routine primary health care.